Log In
Print this Print this

DepoVax-formulated Ebola vaccine

  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionEbola vaccine formulated with ImmunoVaccine's DepoVax vaccine delivery technology, which uses liposomes to encapsulate a target antigen and adjuvant into an oil depot
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsVaccinate against Ebola infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today